100 related articles for article (PubMed ID: 8616830)
1. Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro.
McCotter D; van den Berg HW; Boylan M; McKibben B
Cancer Lett; 1996 Feb; 99(2):239-45. PubMed ID: 8616830
[TBL] [Abstract][Full Text] [Related]
2. Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines.
Maxwell P; van den Berg HW
Cancer Lett; 1999 May; 139(2):121-7. PubMed ID: 10395168
[TBL] [Abstract][Full Text] [Related]
3. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
4. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
[TBL] [Abstract][Full Text] [Related]
5. Reduced levels of cathepsin D associated with tamoxifen resistance and estrogen independence in the ZR-75-1 human breast cancer cell line.
Long BJ; van den Berg HW
Cancer Lett; 1996 Feb; 99(2):233-8. PubMed ID: 8616829
[TBL] [Abstract][Full Text] [Related]
6. Intracellular levels and secretion of insulin-like-growth-factor-binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells. Differential modulation by estrogens in serum-free medium.
Dubois V; Couissi D; Schonne E; Remacle C; Trouet A
Eur J Biochem; 1995 Aug; 232(1):47-53. PubMed ID: 7556169
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS
Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.
Clemmons DR; Camacho-Hubner C; Coronado E; Osborne CK
Endocrinology; 1990 Dec; 127(6):2679-86. PubMed ID: 1701124
[TBL] [Abstract][Full Text] [Related]
10. Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
van den Berg HW; Claffie D; Boylan M; McKillen J; Lynch M; McKibben B
Br J Cancer; 1996 Feb; 73(4):477-81. PubMed ID: 8595162
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
Pratt SE; Pollak MN
Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y
Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578
[TBL] [Abstract][Full Text] [Related]
14. Identification of insulin-like growth factor binding proteins in breast cancer cells.
Yee D; Favoni RE; Lippman ME; Powell DR
Breast Cancer Res Treat; 1991 Mar; 18(1):3-10. PubMed ID: 1713084
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
Parisot JP; Hu XF; DeLuise M; Zalcberg JR
Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.
Adamo ML; Shao ZM; Lanau F; Chen JC; Clemmons DR; Roberts CT; LeRoith D; Fontana JA
Endocrinology; 1992 Oct; 131(4):1858-66. PubMed ID: 1382963
[TBL] [Abstract][Full Text] [Related]
17. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
Vaziri-Gohar A; Zheng Y; Houston KD
Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
[TBL] [Abstract][Full Text] [Related]
19. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.
Long B; McKibben BM; Lynch M; van den Berg HW
Br J Cancer; 1992 Jun; 65(6):865-9. PubMed ID: 1616857
[TBL] [Abstract][Full Text] [Related]
20. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
